Clinic
Community Action Corporation of South Texas
Community Action Corporation of South Texas was paid $4.97M by Medicaid between Jun 2020 and Dec 2024, across 52 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 82% of everything it billed.
33Billing provider infoCOMMUNITY ACTION CORPORATION OF SOUTH TEXAS
FALFURRIAS, TX 78355
FALFURRIAS, TX 78355
33aNPI1184868663assigned 04/28/2009
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$4.97M
24GClaims133,716
24DCodes billed52
24AFirst – last monthJun 2020 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in Texas
Rank by total paid#46 of 248
Median peer was paid$796K
This provider vs. median6.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 3,510 | $184K | |
| 2021 | 28,920 | $1.28M | |
| 2022 | 35,473 | $1.34M | |
| 2023 | 36,318 | $1.20M | |
| 2024incomplete | 29,495 | $970K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 82% | 25,261 | 17,732 | $4.09M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 18,324 | 15,121 | $803K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 725 | 696 | $34K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 524 | 508 | $25K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 346 | 336 | $16K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 94 | 80 | $4K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 38 | 37 | $2K |
| 90658 | <1% | 92 | 92 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 43 | 42 | $1K |
| 0001A | <1% | 44 | 43 | $1K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 568 | 520 | $627.43 |
| 0002A | <1% | 17 | 16 | $560.00 |
40 more codes
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,777 | $393.98 |
| G0467 | Community health center visit, returning patient | <1% | 12 | $270.08 |
| 0071A | <1% | 19 | $200.00 | |
| 92552 | <1% | 2,822 | $6.33 | |
| 87428 | <1% | 338 | $0.29 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 208 | $0.28 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 128 | $0.05 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 700 | $0.01 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 59 | $0.01 |
| 1160F | 0% | 16,548 | $0.00 | |
| 1159F | 0% | 16,912 | $0.00 | |
| 99173 | 0% | 2,976 | $0.00 | |
| 3028F | 0% | 1,009 | $0.00 | |
| 3078F | 0% | 69 | $0.00 | |
| 90670 | 0% | 40 | $0.00 | |
| S5000 | Prescription drug, generic | 0% | 49 | $0.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 13 | $0.00 |
| 1033F | 0% | 96 | $0.00 | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 24 | $0.00 |
| 1003F | 0% | 14 | $0.00 | |
| 90686 | 0% | 662 | $0.00 | |
| 1126F | 0% | 697 | $0.00 | |
| 2010F | 0% | 9,781 | $0.00 | |
| 2001F | 0% | 11,680 | $0.00 | |
| 3008F | 0% | 15,736 | $0.00 | |
| 1170F | 0% | 267 | $0.00 | |
| 2000F | 0% | 399 | $0.00 | |
| 1220F | 0% | 1,895 | $0.00 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 284 | $0.00 |
| 3037F | 0% | 86 | $0.00 | |
| 87807 | 0% | 12 | $0.00 | |
| 3074F | 0% | 187 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 728 | $0.00 |
| 90688 | 0% | 304 | $0.00 | |
| 1000F | 0% | 34 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 16 | $0.00 |
| 1036F | 0% | 14 | $0.00 | |
| 90651 | 0% | 13 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 16 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAWALT, ANN (EXECUTIVE DRIECTOR)
| Provider | Location | Paid |
|---|---|---|
| Community Action Corporation of South Texas | Alice, TX | $35.13M |
| Community Action Corporation of South Texas | Kingsville, TX | $6.08M |
| Community Action Corporation of South Texas | Beeville, TX | $3.24M |
| Community Action Corporation of South Texas | Alice, TX | $2.50M |
| Community Action Corporation of South Texas | Alice, TX | $689K |
| Community Action Corporation of South Texas | Mathis, TX | $582K |
| Community Action Corporation of South Texas | Sinton, TX | $571K |
| Community Action Corporation of South Texas | Sinton, TX | $242K |
| Community Action Corporation of South Texas | Benavides, TX | $119K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.